A phase 3 trial shows that the investigational dopamine-1 receptor antagonist ecopipam is safe and effective for improving Tourette syndrome symptoms in children and adults.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/novel-drug-tourette-syndrome-safe-effective-kids-and-adults-2025a1000rim?src=rss
Author :
Publish date : 2025-10-13 11:37:00
Copyright for syndicated content belongs to the linked Source.
